Related Experiment Video
Updated: Jun 20, 2025

Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry
Published on: October 18, 2016
Macrophage iron dyshomeostasis promotes aging-related renal fibrosis
Lingzhi Wu1, Hongchun Lin1, Shaomin Li1
1Nephrology Division, Department of Medicine, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Abstract:
Renal aging, marked by the accumulation of senescent cells and chronic low-grade inflammation, leads to renal interstitial fibrosis and impaired function. In this study, we investigate the role of macrophages, a key regulator of inflammation, in renal aging by analyzing kidney single-cell RNA sequencing data of C57BL/6J mice from 8 weeks to 24 months. Our findings elucidate the dynamic changes in the proportion of kidney cell types during renal aging and reveal that increased macrophage infiltration contributes to chronic low-grade inflammation, with these macrophages exhibiting senescence and activation of ferroptosis signaling. CellChat analysis indicates enhanced communications between macrophages and tubular cells during aging. Suppressing ferroptosis alleviates macrophage-mediated tubular partial epithelial-mesenchymal transition in vitro, thereby mitigating the expression of fibrosis-related genes. Using SCENIC analysis, we infer Stat1 as a key age-related transcription factor promoting iron dyshomeostasis and ferroptosis in macrophages by regulating the expression of Pcbp1, an iron chaperone protein that inhibits ferroptosis. Furthermore, through virtual screening and molecular docking from a library of anti-aging compounds, we construct a docking model targeting Pcbp1, which indicates that the natural small molecule compound Rutin can suppress macrophage senescence and ferroptosis by preserving Pcbp1. In summary, our study underscores the crucial role of macrophage iron dyshomeostasis and ferroptosis in renal aging. Our results also suggest Pcbp1 as an intervention target in aging-related renal fibrosis and highlight Rutin as a potential therapeutic agent in mitigating age-related renal chronic low-grade inflammation and fibrosis.
Insights
Macrophages drive kidney aging and fibrosis through ferroptosis. Targeting iron metabolism in macrophages with compounds like Rutin may offer therapeutic benefits for age-related kidney disease.
Area of Science:
- Gerontology
- Nephrology
- Immunology
Background:
- Renal aging is characterized by senescent cells and chronic inflammation, leading to fibrosis and dysfunction.
- Macrophages are key inflammatory regulators implicated in age-related kidney damage.
Purpose of the Study:
- To investigate the role of macrophages in renal aging.
- To elucidate the mechanisms of macrophage-driven inflammation and fibrosis.
- To identify potential therapeutic targets for age-related kidney disease.
Main Methods:
- Single-cell RNA sequencing of mouse kidneys across aging spectrum.
- CellChat and SCENIC analyses for cell communication and transcription factor inference.
- In vitro ferroptosis suppression and virtual screening of anti-aging compounds.
Main Results:
- Increased macrophage infiltration in aging kidneys, exhibiting senescence and ferroptosis.
- Macrophage-to-tubular cell communication is enhanced with aging.
- Stat1 and Pcbp1 are identified as key regulators of macrophage ferroptosis.
- Rutin suppresses macrophage senescence and ferroptosis by targeting Pcbp1.
Conclusions:
- Macrophage ferroptosis is a critical driver of renal aging and fibrosis.
- Pcbp1 is a potential therapeutic target for intervention.
- Rutin shows promise as a therapeutic agent for mitigating age-related kidney inflammation and fibrosis.

